Gene therapy: Adenovirus-mediated human bone morphogenetic protein-2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo

Journal of Orthopaedic Research

Volumn 17, Issue 1, 1999, Pages 43-50

  Lou, J ^a   Xu, F ^a   Merkel, K ^a   Manske, P ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL CULTURE; ANTIBODIES; CATALYST ACTIVITY; ENZYMES; GENE TRANSFER; LIVING SYSTEMS STUDIES; VIRUSES;

GENE THERAPY; PHOSPHATASE;

BONE;

BONE MORPHOGENETIC PROTEIN 2; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; CELL PROLIFERATION; CELL SPECIFICITY; GENE TARGETING; GENE THERAPY; GROWTH REGULATION; HUMAN; HUMAN CELL; MESENCHYME; NUDE MOUSE; OSSIFICATION; PRIORITY JOURNAL;

EID: 0032973123     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.1100170108     Document Type: Article

References (26)

1. 1 Ahrens M, Ankenbauer T, Schroder D, Hollnagel A, Mayer H, Gross G: Expression of human bone morphogenetic proteins 2 or 4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into disctinct mesenchymal cell lineage. DNA Cell Biol 12: 871–880, 1993
2. 2 Beresford JN: Osteogenic stem cells and the stromal system of bone and marrow, Clin Orthop 240: 270–280, 1989
3. 3 Bruder SP, Caplan AI: Cellular and molecular events during embryonic bone development. Connect Tissue Res 20: 65–71, 1989
4. 4 Bruder SP, Caplan AI: First bone formation and the dissection of an osteogenic lineage in the embryonic chick tibia is revealed by monoclonal antibodies against osteoblasts. Bone 10: 359–375, 1989
5. 5 Caplan AI: Mesenchymal stem cell‐mediated cartilage and bone repair. In: Biological Mechanisms of Tooth Movement and Craniofacial Adaptation: Proceeding of the International Conference Held at the Great Southern Hotel, Columbus, Ohio, May 8‐11, 1991, pp 433–438. Ed by Z Davidovitch Columbus. Ohio State University, College of Dentistry. 1992
6. 6 Cook SD, Dalton JE, Tan EH, Whitecloud, TS 3rd, Rueger DC: In vivo evaluation of recombinant human osteogenic protein implants as a bone graft substitute for spinal fusions. Spine 19: 1655–1663, 1994
7. 7 Gerhart TN, Kirker‐Head CA, Kriz MJ, Holtrop ME, Hennig GE, Hipp J, Schelling SH, Wang E: Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein. Clin Orthop 293: 317–326, 1993
8. 8 Gitelman SE, Kobrin MS, Ye JQ, Lopez AR, Lee A, Derynck R: Recombinant Vgr‐1/BMP6‐expression tumors induce fibrosis and endochondral bone formation in vivo. J Cell Biol 126: 1595–1609, 1994
9. 9 Goshima J, Goldberg VM, Caplan AI: The origin of bone formed in composite grafts of porous calcium phosphate ceramic loaded with marrow cells. Clin Orthop 269: 274–283, 1991
10. 10 Haynesworth SE, Goshima J, Goldberg VM, Caplan AI: Characterization of cells with osteogenic potential from human marrow. Bone 13: 81–88, 1992
11. 11 Horwitz MS, Tufariello J, Grunhaus A, Fejer G: Model system for studying the effects of adenovirus E3 gene on virulence in vivo. Curr Topics Microbiol Immunol 199: 195–211, 1995
12. 12 Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa‐Sehara A, Suda T: Bone morphogenetc protein‐2 convers the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127: 1755–1766, 1994
13. 13 Lou J, Manske PR, Aoki M, Joyce ME: Adenovirus‐mediated gene transfer into tendon and tendon sheath. J Orthop Res 14: 513–517, 1996
14. 14 Metcalf D: The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature 339: 27–30, 1989
15. 15 Muschler GF, Hyodo A, Manning T, Kambic H, Easley K: Evaluation of human bone morphogenetic protein 2 in a canine spinal fusion model. Clin Orthop 308: 229–240, 1994
16. 16 Preece A: A Manual for Histologic Technicians, pp 57–73. Boston, Little, Brown, and Company, 1972
17. 17 Rosen V, Nove J, Song JJ, Thies RS, Cox K, Wozney JM: Responsiveness of clonal limb bud cell lines to bone morphogenetic protein 2 reveals a sequential relationship between cartilage and bone cell phenotypes. J Bone Miner Res 9: 1759–1768, 1994
18. 18 Toriumi DM, Kotler HS, Luxenberg DP, Holtrop ME, Wang EA: Mandibular reconstruction with a recombinant bone‐inducing factor: functional, histologic, and biomechanical evaluation. Acrh Otolaryngol Head Neck Surg 117: 1101–1112, 1991
19. 19 Wang EA, Rosen V, D'Alessandro JS, Bauduy M, Cordes P, Harada T, Israel DI, Hewick RM, Kerns KM, Lapan P: Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci U S A 87: 2220–2224, 1990
20. 20 Wiles MV, Keller G: Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culure. Development 111: 259–267, 1991
21. 21 Wozney JM: Bone Morphogenetic Proteins in Progress in Growth Factor Research, vol 1, pp 267–280, 1989
22. 22. Wozney JM: The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev 32: 160–167, 1992
23. 23 Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA: Novel regulators of bone formation: molecular clones and activities. Science 242: 1528–1534, 1998
24. 24 Yamaguchi A, Katagiri T, Ikeda T, Wozney JM, Rosen V, Wang EA, Kahn AJ, Suda T, Yoshiki S: Recombinant human bone morphogenetic protein‐2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 113: 681–687, 1991
25. 25 Yasko AW, Lane JM, Fellinger EJ, Rosen V, Wozney JM, Wang EA: The healing of segmental defects, induced by recombinant human bone morphogenetic protein (rhBMP‐2): a radiographic, histological, and biomechanical study in rats. J Bone Joint Surg [Am] 74: 659–670, 1992
26. 26 Yoshikawa H, Rettig WJ, Takaoka K, Alderman E, Rup B, Rosen V, Wozney JM, Lane JM, Huvos AG, Garin‐Chesa P: Expression of bone morphogenetic proteins in human osteosarcoma: immunohistochemical detection with monoclonal antibody. Cancer 73: 85–91, 1994